Want To Know How Your Chicken Filet Was Raised? This Technology May Tell You

“I do have a question about the chicken—can you just tell us a little more about it?” Carrie Brownstein’s character asks of her waitress to learn about her dinner meat in IFC’s hit comedy Portlandia. She and her husband, played by Fred Armisen, continue questioning the waitress about the chicken until she provides the couple with a folder filled with information about the rooster. The diners learn the chicken was named Colin and that he grew up nearby on four acres of land, eating a diet of sheep’s milk, soy and hazelnuts. 

Though this may seem slapstick, consumers’ desire to know where their food’s origins, and to support sustainable and ethical farming, is real. In a 2016 Label Insight survey, 94% of 1,500 consumers said that their purchase decisions are impacted by the manufacturers’ transparency in how the food is made. Further, 71% of these consumers said they consider

Read More
Read More

Amazon Price Target Raised to Wall Street High by Pivotal

Investors and analysts have been framing the Amazon  (AMZN) – Get Report sum-of-the-parts valuation wrong, according to a Pivotal Research analyst, who raised his price target for the internet retail giant to $4,500 from $3,925.

Shares of the Seattle-based Amazon were up 1.6% on Thursday to $3,200.08.

Analyst Michael Levine, who kept a buy rating on the shares, said in a note to clients that Amazon’s advertising was only 5% of revenue, but is a “far greater contributor” to overall non-Amazon Web Services EBIT margins than Wall Street recognizes.

“Said differently,” the analyst said, “if advertising was viewed as a stand-alone business unit … it would represent well north of 300% of 2020E non-AWS EBIT.”

Based on his view that there is “massive upside” to estimates by fiscal year 2024, the analyst increased the firm’s target to a Wall Street-high of $4,500. 

Levine thinks investors are “materially underestimating”

Read More
Read More

Meet The Berkeley Dropout And Berkeley MBA Who Just Raised $3.25 Million For Their No-Code Platform For E-Commerce

Builder, a no-code platform which targets e-commerce websites and was cofounded by Berkeley dropout Steve Sewell and Berkeley MBA Brent Locks, announced today that it has raised $3.25 million in seed funding led by Greylock. Other investors include Warby Parker’s cofounders Dave Gilboa and Neil Blumenthal, Allbirds’ cofounder Joey Zwillinger, Harry’s cofounder Jeff Raider, and PopSugar’s cofounder Brian Sugar.

Builder is a full no-code tool which means that the user can simply drag and drop to create any type of content, particularly in the marketing section.

Steve Sewell, who serves as the company’s CEO, says that when he used to lead web engineering at a company called ShopStyle, they identified that one of the biggest problems was that once a website was built, there wasn’t a lot of tooling around it. 

Sewell says that it would often

Read More
Read More

Emerging biotechnology company Biocytogen raised 142 million dollars (USD) in support of Project Integrum

Press release content from PR Newswire. The AP news staff was not involved in its creation.

BEIJING and BOSTON, Sept. 24, 2020 /PRNewswire/ — In August, Beijing Biocytogen Biotechnology Co., Ltd. (“Biocytogen”) announced acquisition of Eucure Biopharma, which established Biocytogen as a clinical stage company. Now, Biocytogen is pleased to announce completion of series D1 Funding, successfully raising 142 million dollars (USD) meant to further secure the implementation of Project Integrum.

Project Integrum is a humanitarian effort to discover, develop, and bring to market novel therapeutic antibody candidates against all notoriously difficult druggable targets. Taking full advantage of Biocytogen’s integrated technology platforms for antibody discovery, Project Integrum will launch pre-clinical efforts into over 1,000 human diseases currently affecting countless lives.

Meticulous screening of antibody candidates both in vivo and in vitro improves clinical translatability dramatically. At the core of Biocytogen lie the humanized antibody RenMab Mouse

Read More
Read More

Pitch deck: How AR platform Camera IQ raised $5 million

  • Augmented reality platform Camera IQ raised $5 million in Series A funding led by early-stage Silicon Valley investor Shasta Ventures.
  • Camera IQ said augmented reality share rates on Instagram and Facebook increased 43% and 23% respectively during the second quarter.
  • CEO Allison Ferenci says: “[COVID] definitely accelerated both brand adoption, as quite literally we’re living life through the lens of the camera, … and customer adoption.”
  • We got an exclusive look at the pitch deck Camera IQ used to bring new investors on board.
  • Visit Business Insider’s homepage for more stories.

Augmented reality (AR) platform Camera IQ has announced a $5 million Series A led by early-stage Silicon Valley investor Shasta Ventures. The round brings total funding raised to-date to more than $14 million.

Camera IQ’s platform allows businesses to create and manage AR campaigns on social media and streaming platforms such as Instagram, Snapchat, and Zoom. It works with

Read More
Read More